Device-tax repeal will keep U.S. edge in global medtech, exec says

03/27/2013 | Hill, The

The industry already has paid the IRS about $388 million since the 2.3% medical device tax went into effect in January, shifting funds that could otherwise be used to create jobs and advance research and development, writes Siemens Healthcare CEO Greg Sorensen in this article. The passage of the Senate budget amendment to repeal the tax is a key step toward reversing its adverse effects and preserving U.S. leadership in the global medtech industry, he writes.

View Full Article in:

Hill, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC